Step-by-Step Endoscopic Approaches to the Frontal Sinus

Monday, September 30, 2024

8:00 AM – 9:00 AM EDT

Location: MBCC, 244-245

CME/MOC Credit: 1

Disclosure(s):

Jean Anderson Eloy, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Islam R. Herzallah, MD, PhD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: Frontal sinus surgery has long been anatomically challenging in terms of access and chronic disease management. Decades of experience and advents in technology have led to widespread use of varying approaches to the frontal sinus. However, modifications to the existing techniques to minimize unnecessarily invasive procedures and provide adequate treatment have recently been described by the presenters. This presentation will provide a step-by-step approach to the frontal sinus. Appropriate procedure selection will be discussed with case presentations highlighting revision surgery. Variations in typical approaches and utility of balloon dilation in select situations will be discussed. Evidence-based literature on frontal sinus surgery will be reviewed.

Learning Objectives:

Determine which cases are adequate or optimal for surgical intervention.
Describe different endoscopic techniques (including recent modifications) for frontal sinus disease management.
Implement safe and effective management options for frontal sinus surgery.

Lead Presenter(s)

Jean Anderson Eloy, MD

Distinguished Professor and Vice Chairman of Otolaryngology - Head and Neck Surgery
Rutgers New Jersey Medical School
West Orange, New Jersey, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Co-Presenter(s)

Islam R. Herzallah, MD, PhD

Professor of Otolaryngology
KAMC (Makkah, Saudi Arabia) - Zagazig University (Egypt)
Makkah, Makkah, Saudi Arabia

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.